Byhealth Co., Ltd (SHE:300146)

Market Cap	15.41B -20.8%
Revenue (ttm)	6.34B +6.0%
Net Income	729.32M +91.5%
EPS	0.44 +97.8%
Shares Out	1.68B
PE Ratio	20.96
Forward PE	19.17
Dividend	0.45 (4.95%)
Ex-Dividend Date	Apr 21, 2026

Volume	9,174,211
Open	9.15
Previous Close	9.20
Day's Range	9.02 - 9.22
52-Week Range	8.87 - 13.20
Beta	0.43
Analysts	Buy
Price Target	12.43 (+36.59%)
Earnings Date	Aug 8, 2026

About Byhealth

Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management; and OTC licensing and outsourced processing activities. It sells i...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Employees: 2,867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300146

Financial Performance

In 2025, Byhealth's revenue was 6.27 billion, a decrease of -8.38% compared to the previous year's 6.84 billion. Earnings were 782.15 million, an increase of 19.81%.

Analyst Summary

According to 4 analysts, the average rating for 300146 stock is "Buy." The 12-month stock price target is ¥12.43, which is an increase of 36.59% from the latest price.

Price Target

¥12.43

(36.59% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 9, 2026

Data Sources Report a data error